Two-Target cancer therapy delivered by nanoparticles shows promise

This study is testing a new type of CAR-T cell therapy for people with B-cell lymphoma or leukemia that has come back or hasn't responded to standard treatments. Instead of modifying a patient's T cells in a lab, doctors use tiny particles to deliver genetic instructions directly into the body to create cancer-fighting cells. The therapy targets two markers on cancer cells simultaneously, aiming to reduce the chance of the cancer escaping treatment.